Home
·
Products
·
Febrile rash illness viruses
Febrile rash illness viruses
Febrile rash illness viruses differential diagnostic kit

DI Febrile Rash Illness Viruses Multiplex (DIRASH)

RUO
Photo de produit Febrile rash illness viruses
  • Syndromic diagnosis Identification of the main virusess responsibles for febrile rash eruptions.
  • Multiplex qPCR HRM MPXV, VZV, HSV-1, HSV-2, and an endogenous internal control are detected in a single well.
  • Diverse samples From cutaneous-mucous and oropharyngeal samples. 
  • Adaptable and easy to use Easy to use and fast (1 hour post-extraction), transportable at room temperature (freeze dried), adaptable to different thermocyclers (MIC, CFX96, QS5).
  • Automated interpretation The obtained results are then analyzed by an artificial intelligence-based software: DISoft™.
  • Clinically validated Clinical validation of the DIRASH kit in collaboration with the Montpellier University Hospital (CHU) and The National Institute of Biomedical Research  (INRB).

Learn more

The DI Febrile Rash Illness Viruses Multiplex (DIRASH) kit is an in vitro diagnostic medical device intended for the qualitative differential detection of viral DNA responsible for infections with cutaneous-mucosal tropism in human patients presenting with compatible clinical signs, regardless of age or associated conditions.

This device is based on real-time PCR technology combined with high-resolution melting curve analysis (HRM). It allows the simultaneous detection, in a single well, of mpox virus DNA, Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV), as well as the GAPDH gene, used as an endogenous internal control to validate sample quality and the efficiency of extraction and amplification processes.

The device is designed for use with oropharyngeal, cutaneo-mucosal, or serum samples, collected by a qualified healthcare professional. Prior nucleic acid (NA) extraction must be performed using validated methods before PCR amplification.

image description product

Features

Samples Mucocutaneous samples, oropharyngeal swabs
Targets MPXV, VZV, HSV-1 and HSV-2, and GAPDH as an endogenous internal control (NTPC)
Controls Positive Amplification Control (PAC) and endogenous non-target control
Duration ~ 1 hour
Equipment Nucleic acid extraction kits; compatible thermocyclers required (MIC, CFX, or QS5)
Stability 24 monthes
Storage temperature -16°C to -26°C
Shipment temperature ambient
Reference DIRASH-50
Associated product DIMPXV-FD
Discover the DISoft software